Xiaoli Liu , Ruolan Guo , Zhan Qi , Yaodong Zhang , Xiaotun Ren , Wei Li , Xuyun Hu , Chanjuan Hao
{"title":"Genetic screening of EIF2B genes reveals mutation spectrum and predicted prevalence of vanishing white matter disease in Chinese population","authors":"Xiaoli Liu , Ruolan Guo , Zhan Qi , Yaodong Zhang , Xiaotun Ren , Wei Li , Xuyun Hu , Chanjuan Hao","doi":"10.1016/j.cca.2026.120942","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Vanishing White Matter disease (VWM) is a rare autosomal recessive leukoencephalopathy caused by biallelic variants in any of the five subunits of eukaryotic initiation factor 2B (<em>EIF2B1–5</em>), with varied clinical manifestations, including progressive neurological deterioration, cerebellar ataxia, and white matter abnormalities on MRI. Early and accurate diagnosis is crucial for medical interventions and genetic counseling.</div></div><div><h3>Methods</h3><div>We aimed to characterize the prevalence and spectrum of pathogenic variants of VWM in the Chinese population through Genetic screening for VWM mutations in 36,820 Chinese newborns from 31 hospitals across 14 provinces using next-generation sequencing. Pathogenic and likely pathogenic variants were identified and classified according to ACMG guidelines. Prevalence rates and variant spectra were analyzed.</div></div><div><h3>Results</h3><div>Among screened newborns, 114 carriers with 36 distinct pathogenic and likely pathogenic variants were identified, including 18 novel variants. The overall carrier frequency was 1 in 323. <em>EIF2B2</em> showed the highest carrier frequency (1 in 498), with c.254 T > A/p.Val85Glu being a hotspot variant (61/74 carriers, 82.4%). The estimated prevalence rate of VWM in China was 1.12/1,000,000.</div></div><div><h3>Conclusions</h3><div>This large-scale screening provides valuable insights into the genetic landscape of VWM in the Chinese population, contributing to improved genetic counseling, early diagnosis, and management strategies. These findings contribute to enhancing the understanding and management of VWM in China.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"587 ","pages":"Article 120942"},"PeriodicalIF":2.9000,"publicationDate":"2026-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898126001245","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Vanishing White Matter disease (VWM) is a rare autosomal recessive leukoencephalopathy caused by biallelic variants in any of the five subunits of eukaryotic initiation factor 2B (EIF2B1–5), with varied clinical manifestations, including progressive neurological deterioration, cerebellar ataxia, and white matter abnormalities on MRI. Early and accurate diagnosis is crucial for medical interventions and genetic counseling.
Methods
We aimed to characterize the prevalence and spectrum of pathogenic variants of VWM in the Chinese population through Genetic screening for VWM mutations in 36,820 Chinese newborns from 31 hospitals across 14 provinces using next-generation sequencing. Pathogenic and likely pathogenic variants were identified and classified according to ACMG guidelines. Prevalence rates and variant spectra were analyzed.
Results
Among screened newborns, 114 carriers with 36 distinct pathogenic and likely pathogenic variants were identified, including 18 novel variants. The overall carrier frequency was 1 in 323. EIF2B2 showed the highest carrier frequency (1 in 498), with c.254 T > A/p.Val85Glu being a hotspot variant (61/74 carriers, 82.4%). The estimated prevalence rate of VWM in China was 1.12/1,000,000.
Conclusions
This large-scale screening provides valuable insights into the genetic landscape of VWM in the Chinese population, contributing to improved genetic counseling, early diagnosis, and management strategies. These findings contribute to enhancing the understanding and management of VWM in China.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.